Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-018-19753-9.pdf
Reference59 articles.
1. Younossi, Z. M. et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 9, 524–530.e521; quiz e560, https://doi.org/10.1016/j.cgh.2011.03.020 (2011).
2. Vanni, E. et al. From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 42, 320–330, https://doi.org/10.1016/j.dld.2010.01.016 (2010).
3. Rotman, Y., Koh, C., Zmuda, J. M., Kleiner, D. E. & Liang, T. J. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 52, 894–903, https://doi.org/10.1002/hep.23759 (2010).
4. Farrell, G. C. & Larter, C. Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43, S99–S112, https://doi.org/10.1002/hep.20973 (2006).
5. Alam, S., Mustafa, G., Alam, M. & Ahmad, N. Insulin resistance in development and progression of nonalcoholic fatty liver disease. World journal of gastrointestinal pathophysiology 7, 211–217, https://doi.org/10.4291/wjgp.v7.i2.211 (2016).
Cited by 187 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Implications of the gut microbiome in cardiovascular diseases: Association of gut microbiome with cardiovascular diseases, therapeutic interventions and multi-omics approach for precision medicine;Medicine in Microecology;2024-03
2. Ganoderma lucidum ethanol extracts ameliorate hepatic fibrosis and promote the communication between metabolites and gut microbiota g_Ruminococcus through the NF-κB and TGF-β1/Smads pathways;Journal of Ethnopharmacology;2024-03
3. Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism;Journal of Gastroenterology;2024-01-24
4. Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?;European Journal of Internal Medicine;2024-01
5. The pathophysiology of MASLD: an immunometabolic perspective;Expert Review of Clinical Immunology;2023-12-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3